144 related articles for article (PubMed ID: 19603199)
21. Relations between the intracellular pathways of the receptors for transferrin, asialoglycoprotein, and mannose 6-phosphate in human hepatoma cells.
Stoorvogel W; Geuze HJ; Griffith JM; Schwartz AL; Strous GJ
J Cell Biol; 1989 Jun; 108(6):2137-48. PubMed ID: 2544602
[TBL] [Abstract][Full Text] [Related]
22. Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH.
Sipe DM; Murphy RF
J Biol Chem; 1991 May; 266(13):8002-7. PubMed ID: 2022630
[TBL] [Abstract][Full Text] [Related]
23. Nitrogen monoxide decreases iron uptake from transferrin but does not mobilise iron from prelabelled neoplastic cells.
Richardson DR; Neumannova V; Ponka P
Biochim Biophys Acta; 1995 May; 1266(3):250-60. PubMed ID: 7766711
[TBL] [Abstract][Full Text] [Related]
24. Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells.
Voinea M; Dragomir E; Manduteanu I; Simionescu M
Vascul Pharmacol; 2002 Jul; 39(1-2):13-20. PubMed ID: 12616986
[TBL] [Abstract][Full Text] [Related]
25. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
26. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.
Johnson MB; Chen J; Murchison N; Green FA; Enns CA
Mol Biol Cell; 2007 Mar; 18(3):743-54. PubMed ID: 17182845
[TBL] [Abstract][Full Text] [Related]
27. Characterization of transferrin-independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake.
Inman RS; Wessling-Resnick M
J Biol Chem; 1993 Apr; 268(12):8521-8. PubMed ID: 8473296
[TBL] [Abstract][Full Text] [Related]
28. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models.
Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
Mol Pharm; 2012 Jul; 9(7):1919-31. PubMed ID: 22616905
[TBL] [Abstract][Full Text] [Related]
29. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
30. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
[TBL] [Abstract][Full Text] [Related]
31. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells.
Thatte HS; Bridges KR; Golan DE
J Cell Physiol; 1994 Aug; 160(2):345-57. PubMed ID: 7913709
[TBL] [Abstract][Full Text] [Related]
32. Trypanosoma brucei transferrin receptor can bind C-lobe and N-lobe fragments of transferrin.
Steverding D; Sexton DW; Chrysochoidi N; Cao F
Mol Biochem Parasitol; 2012 Oct; 185(2):99-105. PubMed ID: 22776208
[TBL] [Abstract][Full Text] [Related]
33. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
34. Complexation of ytterbium to human transferrin and its uptake by K562 cells.
Du XL; Zhang TL; Yuan L; Zhao YY; Li RC; Wang K; Yan SC; Zhang L; Sun H; Qian ZM
Eur J Biochem; 2002 Dec; 269(24):6082-90. PubMed ID: 12473103
[TBL] [Abstract][Full Text] [Related]
35. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
Richardson DR; Ponka P
Biochim Biophys Acta; 1997 Mar; 1331(1):1-40. PubMed ID: 9325434
[TBL] [Abstract][Full Text] [Related]
36. Multimodal highly fluorescent-magnetic nanoplatform to target transferrin receptors in cancer cells.
Cabral Filho PE; Cabrera MP; Cardoso ALC; Santana OA; Geraldes CFGC; Santos BS; Pedroso de Lima MC; Pereira GAL; Fontes A
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2788-2796. PubMed ID: 30251667
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy.
Yamada Y; Shinohara Y; Kakudo T; Chaki S; Futaki S; Kamiya H; Harashima H
Int J Pharm; 2005 Oct; 303(1-2):1-7. PubMed ID: 16139452
[TBL] [Abstract][Full Text] [Related]
38. Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex.
Sakajiri T; Yamamura T; Kikuchi T; Ichimura K; Sawada T; Yajima H
Biol Trace Elem Res; 2010 Sep; 136(3):279-86. PubMed ID: 19859668
[TBL] [Abstract][Full Text] [Related]
39. Characterization of iron uptake from transferrin by murine endothelial cells.
Hallmann R; Savigni DL; Morgan EH; Baker E
Endothelium; 2000; 7(2):135-47. PubMed ID: 10865941
[TBL] [Abstract][Full Text] [Related]
40. Intermediate steps in cellular iron uptake from transferrin. Detection of a cytoplasmic pool of iron, free of transferrin.
Richardson DR; Baker E
J Biol Chem; 1992 Oct; 267(30):21384-9. PubMed ID: 1400450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
